DK1680096T3 - Hidtil ukendt formulering til retinoidholdige blöde gelatinekapsler - Google Patents
Hidtil ukendt formulering til retinoidholdige blöde gelatinekapslerInfo
- Publication number
- DK1680096T3 DK1680096T3 DK04790978T DK04790978T DK1680096T3 DK 1680096 T3 DK1680096 T3 DK 1680096T3 DK 04790978 T DK04790978 T DK 04790978T DK 04790978 T DK04790978 T DK 04790978T DK 1680096 T3 DK1680096 T3 DK 1680096T3
- Authority
- DK
- Denmark
- Prior art keywords
- soft gelatin
- retinoid
- gelatin capsules
- formulation
- containing soft
- Prior art date
Links
- 239000007903 gelatin capsule Substances 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000004492 retinoid derivatives Chemical class 0.000 title abstract 3
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 2
- 239000008158 vegetable oil Substances 0.000 abstract 2
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 229940057917 medium chain triglycerides Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03405788A EP1527774A1 (en) | 2003-11-03 | 2003-11-03 | New formulation for retinoid-containing soft gelatin capsules |
PCT/EP2004/012208 WO2005048994A1 (en) | 2003-11-03 | 2004-10-28 | New formulation for retinoid-containing soft gelatin capsules |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1680096T3 true DK1680096T3 (da) | 2008-08-04 |
Family
ID=34178692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04790978T DK1680096T3 (da) | 2003-11-03 | 2004-10-28 | Hidtil ukendt formulering til retinoidholdige blöde gelatinekapsler |
Country Status (21)
Country | Link |
---|---|
US (6) | US20050042278A1 (da) |
EP (2) | EP1527774A1 (da) |
JP (1) | JP4555827B2 (da) |
KR (1) | KR100856362B1 (da) |
CN (1) | CN100594894C (da) |
AT (1) | ATE392204T1 (da) |
AU (1) | AU2004290494B2 (da) |
BR (1) | BRPI0415634B8 (da) |
CA (1) | CA2541292C (da) |
CY (1) | CY1108184T1 (da) |
DE (1) | DE602004013178T2 (da) |
DK (1) | DK1680096T3 (da) |
ES (1) | ES2303956T3 (da) |
MX (1) | MXPA06003821A (da) |
NO (1) | NO339743B1 (da) |
NZ (1) | NZ546258A (da) |
PL (1) | PL1680096T3 (da) |
PT (1) | PT1680096E (da) |
RU (1) | RU2344810C2 (da) |
SI (1) | SI1680096T1 (da) |
WO (1) | WO2005048994A1 (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8541469B2 (en) * | 1997-08-23 | 2013-09-24 | Glaxo Group Limited | Treatment of cell-mediated immune diseases |
ES2396560T3 (es) | 2001-12-26 | 2013-02-22 | Research In Motion Limited | Interfaz de usuario y método de ver eventos unificados de comunicaciones en un dispositivo móvil |
US20080112987A1 (en) * | 2006-11-10 | 2008-05-15 | National Starch And Chemical Investment Holding Corporation | Coating for oxygen sensitive materials |
US20110280960A1 (en) * | 2008-12-04 | 2011-11-17 | Juris Rubens | Thick pine needle extract composition for capsulation |
CA2774168C (en) * | 2009-09-15 | 2021-02-23 | Ronald Erwin Boch | Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle |
RU2622763C2 (ru) | 2010-04-19 | 2017-06-19 | Новелион Терапьютикс Инк. | Лечебная схема и способы лечения или уменьшения нарушений зрения, связанных с дефицитом эндогенных ретиноидов |
NZ629267A (en) | 2012-03-01 | 2016-11-25 | Quadra Logic Tech Inc | Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency |
CN102716103B (zh) * | 2012-07-02 | 2013-12-18 | 西安力邦制药有限公司 | 2,2′,6,6′-四异丙基-4,4′-二联苯酚软胶囊制剂及其制备方法 |
WO2018060866A1 (en) * | 2016-09-28 | 2018-04-05 | Dr. Reddy’S Laboratories Limited | Oral retinoid compositions |
CN107157966B (zh) * | 2017-06-14 | 2021-04-13 | 程刚 | 一种纳米包裹视黄醛祛痘凝胶及其制备方法 |
KR102108153B1 (ko) | 2017-07-05 | 2020-05-07 | (주)동구바이오제약 | 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물 |
CN109512795A (zh) * | 2018-12-24 | 2019-03-26 | 浙江安宝药业有限公司 | 维生素a软胶囊 |
CN112618509A (zh) * | 2019-09-24 | 2021-04-09 | 重庆华邦制药有限公司 | 一种维a酸软胶囊及其制备方法 |
RU2744142C1 (ru) * | 2019-12-06 | 2021-03-03 | Общество с ограниченной ответственностью "Артлайф" | Композиция для профилактики грибковых заболеваний |
CN113332258A (zh) * | 2021-06-30 | 2021-09-03 | 山东良福制药有限公司 | 维a酸硬胶囊及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1282326C (en) * | 1984-12-14 | 1991-04-02 | Paul J. Jarosz | Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient |
US5082661A (en) * | 1990-09-26 | 1992-01-21 | Elizabeth Arden Co., Division Of Conopco, Inc. | Odorless cosmetic compositions in gelatin capsules |
ATE193307T1 (de) * | 1992-01-14 | 2000-06-15 | Hisamitsu Pharmaceutical Co | Unvernetztes anion-austauscherharz und diesen enthaltende pharmazeutische zusammensetzung |
CZ282548B6 (cs) * | 1992-01-22 | 1997-08-13 | F. Hoffmann-La Roche Ag | Farmaceutický přípravek |
KR100274101B1 (ko) * | 1992-01-22 | 2000-12-15 | 프리돌린 클라우스너, 롤란드 비. 보레르 | 9-시스 레틴산을 함유하는 약제학적 조성물 |
CA2093577C (en) | 1992-05-07 | 2006-01-03 | Michael Klaus | Alkyl or alkoxy substituted s-heterocyclic retinoids |
DE19603402A1 (de) * | 1995-02-24 | 1996-08-29 | Basf Ag | Weichgelatinekapseln |
KR0173445B1 (ko) * | 1996-09-17 | 1999-02-01 | 이능희 | 화장료용 이중캡슐 및 이를 함유하는 화장료 조성물 |
EP0908179A1 (en) | 1997-08-23 | 1999-04-14 | Werner Bollag | Treatment of cell-mediated immune diseases |
KR20010032000A (ko) * | 1997-11-12 | 2001-04-16 | 프리돌린 클라우스너, 롤란드 비. 보레르 | 레티노이드 길항제를 이용한 티-보조 세포 제2형 중재면역 질환의 치료 |
PE20001227A1 (es) * | 1998-10-30 | 2000-11-06 | Hoffmann La Roche | Procesos para producir una composicion de isotretinoina |
US6248354B1 (en) * | 1999-03-04 | 2001-06-19 | Allergan Sales, Inc. | Capsule system |
US6468559B1 (en) * | 2000-04-28 | 2002-10-22 | Lipocine, Inc. | Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods |
WO2001095856A2 (en) | 2000-06-15 | 2001-12-20 | Chaconne Nsi Co., Ltd. | Urea derivative useful as an anti-cancer agent and process for preparing same |
IN192188B (da) | 2000-06-16 | 2004-03-13 | Ranbaxy Lab Ltd |
-
2003
- 2003-11-03 EP EP03405788A patent/EP1527774A1/en not_active Withdrawn
-
2004
- 2004-10-05 US US10/958,704 patent/US20050042278A1/en not_active Abandoned
- 2004-10-28 CN CN200480032140A patent/CN100594894C/zh active Active
- 2004-10-28 MX MXPA06003821A patent/MXPA06003821A/es active IP Right Grant
- 2004-10-28 KR KR1020067007881A patent/KR100856362B1/ko active Protection Beyond IP Right Term
- 2004-10-28 JP JP2006537192A patent/JP4555827B2/ja active Active
- 2004-10-28 DE DE602004013178T patent/DE602004013178T2/de active Active
- 2004-10-28 ES ES04790978T patent/ES2303956T3/es active Active
- 2004-10-28 RU RU2006119326/15A patent/RU2344810C2/ru active
- 2004-10-28 DK DK04790978T patent/DK1680096T3/da active
- 2004-10-28 AT AT04790978T patent/ATE392204T1/de active
- 2004-10-28 SI SI200430715T patent/SI1680096T1/sl unknown
- 2004-10-28 NZ NZ546258A patent/NZ546258A/en unknown
- 2004-10-28 EP EP04790978A patent/EP1680096B1/en active Active
- 2004-10-28 AU AU2004290494A patent/AU2004290494B2/en active Active
- 2004-10-28 BR BRPI0415634A patent/BRPI0415634B8/pt active IP Right Grant
- 2004-10-28 WO PCT/EP2004/012208 patent/WO2005048994A1/en active IP Right Grant
- 2004-10-28 CA CA2541292A patent/CA2541292C/en active Active
- 2004-10-28 PT PT04790978T patent/PT1680096E/pt unknown
- 2004-10-28 PL PL04790978T patent/PL1680096T3/pl unknown
-
2006
- 2006-04-28 NO NO20061890A patent/NO339743B1/no unknown
-
2008
- 2008-07-09 CY CY20081100720T patent/CY1108184T1/el unknown
-
2009
- 2009-12-17 US US12/640,325 patent/US8697122B2/en active Active
-
2011
- 2011-04-14 US US13/086,479 patent/US9084823B2/en active Active
-
2014
- 2014-02-27 US US14/191,785 patent/US9084824B2/en active Active
-
2015
- 2015-06-09 US US14/734,249 patent/US9399023B2/en active Active
-
2016
- 2016-06-24 US US15/192,191 patent/US20160367488A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20061890L (no) | Ny formulering for retinoid-inneholdende blote gelatinkapsler | |
AR051237A1 (es) | Sistema de capsula blanda sin gelatina | |
EP2279729A3 (en) | Controlled release preparations | |
NO20020055L (no) | Blanding egnet for a danne en myk kapsel, samt spiselig myk kapsel. | |
CL2008000742A1 (es) | Boca dispensadora de ingredientes, que comprende una tapa, una capsula con ingredientes, un alojamiento de capsula que contiene la capsula con ingredientes y una base; y metodo para liberar un ingrediente dentro de un envase. | |
ITBO20030062A1 (it) | Capsula utilizzabile per la preparazione di una bevanda infusa. | |
WO2005013887A3 (en) | Cosmetic compositions with a structuring agent | |
CL2004000224A1 (es) | Formulacion farmaceutica estable que comprende una inmunoglobulina, un tampon fosfato, un polisorbato y cloruro de sodio, metodo de preparacion y su uso. | |
NO20053994D0 (no) | Fettsyrer med middels kjedelengde, glycerider og analoger som stimulatorer av erytropoese | |
JP2008521942A5 (da) | ||
BRPI0509971A (pt) | uma forma de dosagem farmacêutica, comprimido e método de preparação | |
HUP0303272A3 (en) | Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators, pharmaceutical compositions containing them and their use | |
ATE461882T1 (de) | Verpacktes nahrungsmittel | |
WO2005107709A3 (en) | Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients | |
DK1858494T3 (da) | Hidtil ukendte blöde gelatinekapsler | |
TW200618802A (en) | Pharmaceutical composition in the form of a gastric retention tablet containing an active ingredient | |
AR042677A1 (es) | Composiciones y metodos de cuidado oral | |
UY28148A1 (es) | Bromhidrato de escitalopram y un metodo para su preparacion | |
RU2012112939A (ru) | Ароматизированные капсулы | |
NO20040614L (no) | Preparater som inneholder konjugert linolalkohol. | |
BR0314787A (pt) | Forma de dosagem de liberação modificada | |
CO4970832A1 (es) | Nuevas formulaciones y procesos para su fabricacion | |
WO2004010972A3 (en) | Pellicle-resistant gelatin capsule | |
DE602008000022D1 (de) | Zusammengesetztes essbares Produkt mit Glyceridöl | |
AR022442A1 (es) | Una composicion antitranspirante con cera microcristalina |